PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Twist Bioscience Enters into Multiple Agreement with Astellas to Identify Antibodies & Reduce Tumor Microenvironment-Mediated Immunosuppression

Twist Bioscience Enters into Multiple Agreement with Astellas to Identify Antibodies & Reduce Tumor Microenvironment-Mediated Immu...

May 9, 2022

Exclusive Interview with PharmaShots: Todd Zavodnick of Dermavant Shares Insight on the Appointment of Nancy Beesley with 25+ Years of Experience

Exclusive Interview with PharmaShots: Todd Zavodnick of Dermavant Shares Insight on the Appointment of Nancy Beesley with 25+ Year...

May 9, 2022

The US FDA Extends Review Period of Myfembree’s sNDA to Treat Moderate to Severe Pain Associated with Endometriosis

The US FDA Extends Review Period of Myfembree’s sNDA to Treat Moderate to Severe Pain Associated with Endometriosis

May 9, 2022

Oxurion Reports Results of THR-687 in Part A of P-II (INTEGRAL) Trial for the Treatment of Diabetic Macular Edema

Oxurion Reports Results of THR-687 in Part A of P-II (INTEGRAL) Trial for the Treatment of Diabetic Macular Edema

May 9, 2022

Elpiscience Partner Compass Report Interim Results of ES104 + Paclitaxel in P-II Study for the Treatment of Biliary Tract Cancers

Elpiscience Partner Compass Report Interim Results of ES104 + Paclitaxel in P-II Study for the Treatment of Biliary Tract Cancers

May 9, 2022

Nykode Reports Interim Results of VB10.16 in P-II (VB C-02) Trial for the Treatment of Advanced Cervical Cancer

Nykode Reports Interim Results of VB10.16 in P-II (VB C-02) Trial for the Treatment of Advanced Cervical Cancer

May 9, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us